Wockhardt informs about press release

03 Apr 2017 Evaluate

Wockhardt has informed about Press Release titled ‘Wockhardt receives acknowledgement of its breakthrough superdrug Antibiotic WCK 5222 for Phase III Clinical Trial from US FDA’.

The above information is a part of company’s filings submitted to BSE.

Wockhardt Share Price

1405.00 -13.05 (-0.92%)
20-Jan-2026 11:11 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1656.95
Dr. Reddys Lab 1169.00
Cipla 1390.00
Zydus Lifesciences 881.00
Lupin 2164.80
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×